mva-nef
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2005 (NCT00189930)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva-nef
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00189930 | Phase 2 | Apr 1, 2005 | Bavarian Nordic, National Institutes of Health (NIH), University of Erlangen-Nuremberg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bavarian Nordic | For profit | 1 | 1 | 1 | 2005 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2005 |
| University of Erlangen-Nuremberg | Academic/Hospital | 1 | 0 | 1 | 2005 |
3 organizations
Page 1 / 1